Task: Answer the multiple-choice question.
Question: Which drug exhibits a -17.374% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) C=C(C)C1CC=C(CN2CCN(Cc3ccccc3)CC2)CC1
b) COc1ccc(NC(=O)CSc2nnc(-c3ccc(F)cc3)o2)cn1
c) O=C(Nc1ccc(F)cc1F)c1ccc2nc(N3CCOCC3)sc2c1
Answer: b. COc1ccc(NC(=O)CSc2nnc(-c3ccc(F)cc3)o2)cn1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(NC(=O)CSc2nnc(-c3ccc(F)cc3)o2)cn1
COc1ccc(NC(=O)CSc2nnc(-c3ccc(F)cc3)o2)cn1
2-[[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(6-methoxypyridin-3-yl)acetamide